David Larsen
Stock Analyst at BTIG
(0.20)
# 4,565
Out of 4,703 analysts
601
Total ratings
36.5%
Success rate
-4.1%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DH Definitive Healthcare | Reiterated: Hold | n/a | $1.04 | - | 10 | Sep 4, 2026 | |
| HQY HealthEquity | Maintained: Buy | $115 | $98.54 | +16.70% | 32 | Aug 28, 2026 | |
| MDLN Medline | Maintained: Buy | $55 | $36.27 | +51.64% | 8 | Aug 27, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $340 | $281.06 | +20.97% | 14 | Aug 26, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $100 → $110 | $90.65 | +21.35% | 16 | Aug 19, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | n/a | $1.71 | - | 26 | Aug 19, 2026 | |
| LFST LifeStance Health Group | Maintained: Buy | $16 → $18 | $12.94 | +39.10% | 8 | Aug 19, 2026 | |
| DCGO DocGo | Maintained: Hold | n/a | $0.4161 | - | 19 | Aug 18, 2026 | |
| HIMS Hims & Hers Health | Rated: Hold | n/a | $27.91 | - | 13 | Aug 11, 2026 | |
| CCSI Consensus Cloud Solutions | Maintained: Buy | $45 → $50 | $35.14 | +42.29% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $35 | $21.95 | +59.45% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $38.37 | +69.40% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $20.82 | +68.11% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $15.87 | +57.53% | 32 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $9 | $3.08 | +192.21% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.19 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $60.58 | +48.56% | 19 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.43 | - | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $40 | $26.71 | +49.76% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $4.22 | +89.57% | 51 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $5.97 | +50.88% | 12 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $19 | $18.46 | +0.22% | 18 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.51 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $35.15 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $266.60 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.16 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $87.26 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $337.96 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $289.83 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $97.95 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $248.24 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $9 | $1.24 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $925.96 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.88 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
Definitive Healthcare
Sep 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.04
Upside: -
HealthEquity
Aug 28, 2026
Maintained: Buy
Price Target: $115
Current: $98.54
Upside: +16.70%
Medline
Aug 27, 2026
Maintained: Buy
Price Target: $55
Current: $36.27
Upside: +51.64%
Veeva Systems
Aug 26, 2026
Maintained: Buy
Price Target: $340
Current: $281.06
Upside: +20.97%
Henry Schein
Aug 19, 2026
Maintained: Buy
Price Target: $100 → $110
Current: $90.65
Upside: +21.35%
Health Catalyst
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.71
Upside: -
LifeStance Health Group
Aug 19, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $12.94
Upside: +39.10%
DocGo
Aug 18, 2026
Maintained: Hold
Price Target: n/a
Current: $0.4161
Upside: -
Hims & Hers Health
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $27.91
Upside: -
Consensus Cloud Solutions
Aug 10, 2026
Maintained: Buy
Price Target: $45 → $50
Current: $35.14
Upside: +42.29%
Aug 10, 2026
Rated: Buy
Price Target: $30 → $35
Current: $21.95
Upside: +59.45%
Aug 9, 2026
Maintained: Buy
Price Target: $65
Current: $38.37
Upside: +69.40%
Aug 9, 2026
Maintained: Buy
Price Target: $35
Current: $20.82
Upside: +68.11%
Aug 7, 2026
Maintained: Buy
Price Target: $25
Current: $15.87
Upside: +57.53%
Aug 6, 2026
Rated: Buy
Price Target: $10 → $9
Current: $3.08
Upside: +192.21%
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $13.19
Upside: -
Aug 3, 2026
Maintained: Buy
Price Target: $90
Current: $60.58
Upside: +48.56%
Jul 29, 2026
Rated: Hold
Price Target: n/a
Current: $6.43
Upside: -
Jul 24, 2026
Maintained: Buy
Price Target: $30 → $40
Current: $26.71
Upside: +49.76%
Jul 16, 2026
Rated: Buy
Price Target: $8
Current: $4.22
Upside: +89.57%
Jul 15, 2026
Maintained: Buy
Price Target: $9
Current: $5.97
Upside: +50.88%
Jun 16, 2026
Rated: Hold
Price Target: $19
Current: $18.46
Upside: +0.22%
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $26.51
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $35.15
Upside: -
Feb 5, 2026
Maintained: Hold
Price Target: n/a
Current: $266.60
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $9.16
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $87.26
Upside: -
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $337.96
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $289.83
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $97.95
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $248.24
Upside: n/a
Oct 31, 2018
Maintained: Hold
Price Target: $17 → $9
Current: $1.24
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $925.96
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.88
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a